SP216THE PROGNOSTIC VALUE OF VOLUME STATUS ASSESSMENT BY BIOELECTRICAL IMPEDANCE ANALYSIS AND LUNG ULTRASOUND ON MORTALITY IN SEPTIC ACUTE KIDNEY INJURY PATIENTS UNDERGOING CONTINUOUS RENAL REPLACEMENT THERAPY

IntroductionMonitoring patient with anorexia nervosa (AN) include clinical, biological and psychological factors. In recent years many researchers criticize the BMI as useful measure for controlling evolution of AN.ObjectivesBioelectrical impedance analysis (BIA) is one of the main methods for nutritional status assessment.AimsThe aim of this study was the assessment of the nutrition status in a group of patients with anorexia nervosa in comparison to healthy population (HP).MethodsThe study involved 37 participants: 21 patients with AN and 16 healthy volunteers constituting the control group (HP). The patients were divided into two groups according a BMI: I group 14 < BMI < 15,5 (n = 11; age 18.0 ± 4.37) and II group: 15,5 < BMI < 17,5 (n = 10; age 17.82 ± 3.68). The mean age of HP was 17.68 ± 1.57 and BMI 20.56 ± 1.16 kg/m2. BIA was performed by using ImpediMed bioimpedance analysis SFB7 BioImp. The parameters: phase angle (PA), TBW%, ECW, ICW, ECW/ICW were analyzed.ResultsPA was decreased significantly in the I (4.5°±0,6) and II group (4.7°±0,6) of AN patients’ in comparison with HP (5.6°±0,7). TBW was 9% higher in I group and ECW was increased 6% in the both AN groups compared with HP (P < 0.01). Additionally ECW/ICW ratio indicated the higher transfer of water into the extracellular compartment in AN group (P < 0.01).ConclusionsBIA is accurate tool to indicate the valuable indicators of detecting malnutrition in AN. Further studies are needed to validate the significance of these parameters for the full identification of the nutrition status of AN patients’.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Download Full-text

Change in alkaline phosphatase activity associated with intensive care unit and hospital length of stay in patients with septic acute kidney injury on continuous renal replacement therapy

BMC Nephrology ◽

10.1186/s12882-018-1028-9 ◽

2018 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Seung Don Baek ◽

Jae-Young Kang ◽

Hoon Yu ◽

Seulgi Shin ◽

Hyang-Sook Park ◽

...

Keyword(s):

Intensive Care Unit ◽

Acute Kidney Injury ◽

Alkaline Phosphatase ◽

Intensive Care ◽

Renal Replacement Therapy ◽

Length Of Stay ◽

Kidney Injury ◽

Hospital Length ◽

Hospital Length Of Stay ◽

Septic Acute Kidney Injury

Download Full-text

Acute kidney injury in heart failure

10.1093/med/9780199592548.003.0248 ◽

2015 ◽

Cited By ~ 1

Author(s):

Dinna N. Cruz ◽

Anna Giuliani ◽

Claudio Ronco

Keyword(s):

Heart Failure ◽

Acute Kidney Injury ◽

Kidney Injury ◽

Volume Overload ◽

Bioelectrical Impedance ◽

Impedance Analysis ◽

Cardiorenal Syndrome ◽

Renal Diseases ◽

Consensus Definition ◽

Short And Long Term

Acute kidney injury (AKI) occurring during heart failure (HF) has been labelled cardiorenal syndrome (CRS) type 1. CRS is defined as a group of ‘disorders of the heart and kidneys whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other’. This consensus definition was proposed by the Acute Dialysis Quality Initiative, with the aim to standardize those disorders where cardiac and renal diseases coexist. Five subtypes have been proposed, according to which organ is affected first (cardiac vs renal) and whether the dysfunction is acute or chronic. Another subtype which includes systemic conditions leading to both heart and kidney dysfunction is also described.The term ‘worsening renal function’ has been regularly used to describe the acute and/or subacute changes that occur in the kidneys following HF. However, the AKI classification according to the current consensus definition better represents the entire spectrum of AKI in the setting of HF.The pathophysiology of heart–kidney interaction is complex and still poorly understood. Factors beyond the classic haemodynamic mechanisms appear to be involved: neurohormonal activation, venous congestion, and inflammation have all been implicated.Diuretics are still a cornerstone in the management of HF. Intravenous administration by bolus or continuous infusion appears to be equally efficacious. Biomarkers and bioelectrical impedance analysis can be helpful in estimating the real volume overload and may be useful to predict and avoid AKI. The role of ultrafiltration remains controversial, and it is currently recommended only for diuretic-resistant patients as it has not been associated with better outcomes. The occurrence of AKI during HF is associated with substantially greater short- and long-term mortality.

Download Full-text